Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oral sulphate solution (OSS) is an osmotic laxative formulation used for bowel cleansing prior to colonoscopy or other medical procedures requiring a clear colon. It typically consists of a combination of sodium sulfate, potassium sulfate, and magnesium sulfate. The solution works by creating an osmotic gradient in the intestinal tract, which prevents the absorption of water and promotes the accumulation of fluid in the bowel lumen. This increased volume stimulates peristalsis and leads to effective evacuation of the colon. OSS is noted for its high efficacy in bowel preparation, often achieving superior cleansing compared to traditional polyethylene glycol (PEG) solutions, and is associated with high patient adherence due to its relatively low volume requirements. In China, it is evaluated in real-world practice for colorectal neoplasm screening indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium sulfate + magnesium sulfate + potassium sulfate (Peking Union Medical College Hospital).